Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

Software Treatment for Actively Reducing Severity of ADHD

ClinicalTrials.gov ID: NCT02674633

Public ClinicalTrials.gov record NCT02674633. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Controlled, Parallel-group, Intervention Study to Assess At-home, Game-based Digital Therapy for Treating Pediatric Participants Ages 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)

Study identification

NCT ID
NCT02674633
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Akili Interactive Labs, Inc.
Industry
Enrollment
348 participants

Conditions and interventions

Interventions

  • AKL-T01 Device
  • AKL-T09 Device

Device

Eligibility (public fields only)

Age range
8 Years to 12 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2016
Primary completion
Jul 30, 2017
Completion
Aug 30, 2017
Last update posted
Aug 13, 2020

2016 – 2017

United States locations

U.S. sites
20
U.S. states
14
U.S. cities
20
Facility City State ZIP Site status
Harmonex Neuroscience Research Dothan Alabama 36303
Melmed Center Scottsdale Arizona 85254
Avida, Inc. Newport Beach California 92660
University of California Davis MIND Institute Sacramento California 95817
University of California, San Francisco San Francisco California 94143
Meridien Research Bradenton Florida 34208
Florida Clinical Research Center Maitland Florida 32751
Capstone Clinical Research Libertyville Illinois 60048
Kennedy Krieger Institute Baltimore Maryland 21205
South Shore Psychiatric Services Marshfield Massachusetts 02050
Midwest Research Group Saint Charles Missouri 63304
Center for Psychiatry and Behavioral Medicine Las Vegas Nevada 89128
Duke Child and Family Study Center Durham North Carolina 27705
The Neuropsychiatric Clinic at Carolina Partners Raleigh North Carolina 27606
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229
IPS Research Company Oklahoma City Oklahoma 73103
FutureSearch Trials Dallas Texas 75231
Bayou City Research, Ltd Houston Texas 77007
Northwest Clinical Research Center Bellevue Washington 98007
Seattle Children's Seattle Washington 98121

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02674633, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 13, 2020 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02674633 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →